Patent application submitted to protect new technology
SpectraCure has submitted a new patent application to the European Patent Office. The patent application regards the technical solution used in the new generation of SpectraCure's treatment system. The technology makes it possible to use the same optical fiber for both treatment and dose monitoring; together with the IDOSE software, this is what makes the SpectraCure method unique. In SpectraCure's existing system, the same functionality is achieved by means of a motor-driven fiber-optical switch. By contrast, the novel technology covered by the patent application uses only fixed